Home
13 Mar 2008
CHANGE OF BROKER
The Directors of Henderson Morley plc, the drug discovery company, are pleased to announce the appointment of Hybridan LLP as the Company’s sole broker with immediate effect.
Brewin Dolphin remains the Company’s Nominated Adviser.
Home | Company Profile | News & Events | Scientific Programme | Licensing | Investor Relations | Feedback | Contact Us